Exin Therapeutics

Exin Therapeutics YC 지원서

Winter 2025Active

Exin Therapeutics은(는) Winter 2025 배치에서 Healthcare 회사로 Y Combinator를 거쳤습니다. 아래에는 회사의 사업 내용, 창립자, 그리고 실제 YC 양식에 맞춰 재구성한 YC 지원서가 있습니다.

YC 배치
Winter 2025
산업
HealthcareTherapeutics
팀 규모
9
상태
Active
출시됨
2025

창업자

  • Gabriel Ocana Santero
    Gabriel Ocana SanteroFounder
  • Marko Tvrdic
    Marko TvrdicFounder

Exin Therapeutics의 사업 내용

We use AI and high-throughput mouse studies to discover therapeutics that modify neural activity in the brain. The initial focus is on epilepsies associated with autism and Parkinson’s disease with the potential to expand to any neurological disorder underlined by a dysfunction in neural activity. Our R&D is guided by AI models trained on high-density multimodal mouse data generated in-house. We are 3 Oxford-trained neuroscientists supported by an experienced SAB from Harvard, Science Corp (ex-Neuralink), EPFL, Meta, and UCL. In 1.5 months since landing in SF, we went from nothing to (1) opening and operating an animal lab in South SF, (2) obtaining a proof-of-concept in mice, (3) building a multimodal AI model that directs our screening approach and (4) submitting two provisional patents; all while utilizing less than 50% of our YC funding.

Exin Therapeutics의 YC 지원서, 재구성됨

Y Combinator 지원

Exin Therapeutics, Winter 2025 기수. 공개 데이터를 기반으로 작성된 실제 지원 질문.

  1. Founders2
  2. Company7
  3. Progress7
  4. Idea4
  5. Equity3
  6. Curious2
  7. Batch Preference1

Company

Company name

Exin Therapeutics

Describe what your company does in 50 characters or less.

AI drug discovery platform for neurotherapeutics

What is your company going to make? Please describe your product and what it does or will do.

We are building an AI-driven platform that analyzes high-density multimodal mouse data to discover drugs that modify neural activity. Initially, we target epilepsies associated with autism and Parkinson's disease, but our approach could extend to other neurological disorders involving dysfunctional neural activity.

Where do you live now, and where would the company be based after YC?

We live in San Francisco, CA, and the company is based here post-YC.

Explain your decision regarding location.

We are in San Francisco to be close to biotech investors, collaborators, and research talent. Setting up an animal lab here allows fast iteration between AI insights and in vivo validation, which is key for our approach.

전체 지원서에서 21개의 추가 답변

Founders, Progress, Idea, Equity, Curious, Batch Preference는 전체 버전에 있습니다. 무료 계정을 만들어 YC Insights에서 모든 YC 배치 옆에 열어보세요.

자주 묻는 질문

Exin Therapeutics의 실제 YC 지원서인가요?

아닙니다. Y Combinator는 제출된 지원서를 비공개로 유지합니다. 이것은 재구성된 것입니다. 실제 YC 양식 질문에 Exin Therapeutics의 공개 데이터(출시 노트, 창업자 배경, 제품 설명)를 기반으로 답변했습니다. Exin Therapeutics과 같은 회사가 YC에 어떻게 자신을 소개하는지 보여주며, 그들이 제출한 텍스트는 아닙니다.

Exin Therapeutics은(는) 어떤 YC 배치에 있었나요?

Exin Therapeutics은(는) Y Combinator Winter 2025 배치에 참여했습니다.

Exin Therapeutics은(는) 누가 설립했나요?

Exin Therapeutics은(는) Gabriel Ocana Santero, Marko Tvrdic(이)가 설립했습니다.

Exin Therapeutics은(는) 무엇을 하나요?

AI drug discovery platform for neurotherapeutics

전체 재구성된 지원서를 어떻게 읽나요?

무료 Round Funded 계정을 만드세요. Exin Therapeutics의 전체 26개 질문 버전 지원서와 모든 YC 배치 지원서는 YC Insights에서 확인할 수 있습니다.

Exin Therapeutics과(와) 같은 다른 YC 스타트업